Plainsboro, NJ, United States of America

Jin Yang

This inventor holds 2 USPTO granted patents. Top assignee: Princeton Biomeditech Corporation. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin Yang. Retrieved from https://idiyas.com/inventor/jin-yang-tvptd9in

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jin Yang in Medical Diagnostics

Introduction

Jin Yang is an accomplished inventor based in Plainsboro, NJ (US), known for his significant contributions to the field of medical diagnostics. With a total of 2 patents to his name, he has made strides in developing innovative solutions for detecting critical biomarkers.

Latest Patents

Jin Yang's latest patents include a monoclonal antibody against D-dimer and a diagnostic agent for detecting D-dimer, crosslinked fibrin, and its derivatives. These patents disclose an immunochemical assay device and a method for using this device to detect various targets or markers, such as Cardiac Troponin I, NT-pro-BNP, D-dimer, and cross-linked fibrin in fluid samples. This innovation holds promise for improving diagnostic accuracy in clinical settings.

Career Highlights

Jin Yang is currently associated with Princeton Biomeditech Corporation, where he continues to advance his research and development efforts. His work focuses on enhancing diagnostic tools that can lead to better patient outcomes.

Collaborations

Jin Yang collaborates with Jemo Kang, a talented woman in the field, contributing to the innovative projects at Princeton Biomeditech Corporation.

Conclusion

Jin Yang's work exemplifies the impact of innovation in medical diagnostics, showcasing his dedication to improving healthcare through his inventions. His contributions are paving the way for advancements in the detection of critical health markers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…